GPA

GPA Pharmaceuticals is a Cyprus-based pharmaceutical company that serves as a key distributor and representative for global pharmaceutical leaders, most notably Pfizer. The company manages a broad portfolio of prescription medicines and vaccines across critical therapeutic areas, including oncology, immunology, cardiology, and neurology. Since its acquisition by the Costas Papaellinas Organization (CPO), GPA Pharmaceuticals has operated as a specialized arm for the distribution and commercialization of high-value therapeutics in the Mediterranean region. Its business model focuses on ensuring patient access to innovative treatments for rare diseases and chronic conditions through strategic partnerships with multinational biopharma entities.